Estrogen receptor-β gene polymorphism and colorectal cancer risk: Effect modified by body mass index and isoflavone intake

International Journal of Cancer

Volumn 132, Issue 4, 2012, Pages 951-958

  Honma, Naoko ^a   Yamamoto, Ken ^b   Ohnaka, Keizo ^c   Morita, Makiko ^c   Toyomura, Kengo ^c   Kono, Suminori ^c   Muramatsu, Masaaki ^d   Arai, Tomio ^a   Ueki, Takashi ^c   Tanaka, Masao ^c   Kakeji, Yoshihiro ^c   Maehara, Yoshihiko ^c   Okamura, Takeshi ^e   Ikejiri, Koji ^f   Futami, Kitaroh ^g   Maekawa, Takafumi ^g   Yasunami, Yohichi ^h   Takenaka, Kenji ⁱ   Ichimiya, Hitoshi ^j   Terasaka, Reiji ^k  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e NATIONAL KYUSHU CANCER CENTER   (Japan)

^f NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^g Fukuoka University Chikushi Hospital   (Japan)

^h FUKUOKA UNIVERSITY   (Japan)

ⁱ Fukuoka City Hospital   (Japan)

^j HAMANOMACHI HOSPITAL   (Japan)

^k FUKUOKA RED CROSS HOSPITAL   (Japan)

more..

Author keywords

age; body mass index; colorectal cancer; estrogen receptor CA repeat polymorphism; isoflavone

Indexed keywords

ADENINE; CYTOSINE; ESTROGEN RECEPTOR BETA; FLUORESCEIN; GENOMIC DNA; ISOFLAVONE;

ADULT; AGED; ARTICLE; BODY MASS; CANCER GENETICS; CANCER RISK; CASE CONTROL STUDY; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; DISEASE ASSOCIATION; DNA POLYMORPHISM; ESTROGEN RECEPTOR BETA GENE; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL;

ALLELES; BODY MASS INDEX; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; ESTROGEN RECEPTOR BETA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ISOFLAVONES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84871377943     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27688     Document Type: Article

References (37)

1. Kennelly R, Kavanagh DO, Hogan AM, et al. Oestrogen and the colon: potential mechanisms for cancer prevention. Lancet Oncol 2008; 9: 385-91. (Pubitemid 351411655)
2. Barone M, Tanzi S, Lofano K, et al. Estrogens, phytoestrogens and colorectal neoproliferative lesions. Genes Nutr 2008; 3: 7-13.
3. Beral V, Banks E, Reeves G,. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 2002; 360: 942-4. (Pubitemid 35283842)
4. Calle EE, Miracle-McMahill HL, Thun MJ, et al. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J Natl Cancer Inst 1995; 87: 517-23.
5. Clendenen TV, Koenig KL, Shore RE, et al. Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2009; 18: 275-81.
6. Gunter MJ, Hoover DR, Yu H, et al. Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res 2008; 68: 329-37. (Pubitemid 351380136)
7. Zervoudakis A, Strickler HD, Park Y, et al. Reproductive history and risk of colorectal cancer in postmenopausal women. J Natl Cancer Inst 2011; 103: 826-34.
8. Sato R, Suzuki T, Katayose Y, et al. Steroid sulfatase and estrogen sulfotransferase in colon carcinoma: regulators of intratumoral estrogen concentrations and potent prognostic factors. Cancer Res 2009; 69: 914-22.
9. Tsukamoto K, Inoue S, Hosoi T, et al. Isolation and radiation hybrid mapping of dinucleotide repeat polymorphism at the human estrogen receptor beta locus. J Hum Genet 1998; 43: 73-4. (Pubitemid 28252557)
10. Ogawa S, Hosoi T, Shiraki M, et al. Association of estrogen receptor beta gene polymorphism with bone mineral density. Biochem Biophys Res Commun 2000; 269: 537-41. (Pubitemid 30440336)
11. Scariano JK, Simplicio SG, Montoya GD, et al. Estrogen receptor beta dinucleotide (CA) repeat polymorphism is significantly associated with bone mineral density in postmenopausal women. Calcif Tissue Int 2004; 74: 501-8. (Pubitemid 38780285)
12. Shearman AM, Karasik D, Gruenthal KM, et al. Estrogen receptor beta polymorphisms are associated with bone mass in women and men: the Framingham Study. J Bone Miner Res 2004; 19: 773-81. (Pubitemid 41094389)
13. Takeo C, Negishi E, Nakajima A, et al. Association of cytosine-adenine repeat polymorphism of the estrogen receptor-beta gene with menopausal symptoms. Gend Med 2005; 2: 96-105. (Pubitemid 40867870)
14. Takeo C, Ugai K, Araki J, et al. Pharmacogenetics of hormone replacement therapy for climacteric symptoms. Biochem Biophys Res Commun 2008; 374: 604-8.
15. Forsell C, Enmark E, Axelman K, et al. Investigations of a CA repeat in the oestrogen receptor beta gene in patients with Alzheimer's disease. Eur J Hum Genet 2001; 9: 802-4. (Pubitemid 33019169)
16. Honma N, Arai T, Takubo K, et al. Oestrogen receptor-beta CA repeat polymorphism is associated with incidence of colorectal cancer among females. Histopathology 2011; 59: 216-24.
17. Slattery ML, Sweeney C, Murtaugh M, et al. Associations between ERalpha, ERbeta, and AR genotypes and colon and rectal cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 2936-42. (Pubitemid 43068828)
18. Mahabir S, Baer DJ, Johnson LL, et al. Usefulness of body mass index as a sufficient adiposity measurement for sex hormone concentration associations in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2006; 15: 2502-7. (Pubitemid 46048312)
19. Kono S, Toyomura K, Yin G, et al. A case-control study of colorectal cancer in relation to lifestyle factors and genetic polymorphisms: design and conduct of the Fukuoka colorectal cancer study. Asian Pac J Cancer Prev 2004; 5: 393-400.
20. Uchida K, Kimura Y, Shirota T, et al. Validity and reproducibility of the PC-assisted dietary interview used in the Fukuoka Colorectal Cancer Study. Asian Pac J Cancer Prev 2007; 8: 583-90.
21. Isomura K, Kono S, Moore MA, et al. Physical activity and colorectal cancer: the Fukuoka Colorectal Cancer Study. Cancer Sci 2006; 97: 1099-104. (Pubitemid 44322560)
22. Budhathoki S, Joshi AM, Ohnaka K, et al. Soy food and isoflavone intake and colorectal cancer risk: the Fukuoka colorectal cancer study. Scand J Gastroenterol 2011; 46: 165-72.
23. Geng L, Yao Z, Yang H, et al. Association of CA repeat polymorphism in estrogen receptor beta gene with postmenopausal osteoporosis in Chinese. J Genet Genomics 2007; 34: 868-76. (Pubitemid 47562330)
24. Westberg L, Baghaei F, Rosmond R, et al. Polymorphisms of the androgen receptor gene and the estrogen receptor beta gene are associated with androgen levels in women. J Clin Endocrinol Metab 2001; 86: 2562-8. (Pubitemid 32545707)
25. Moore JT, McKee DD, Slentz-Kesler K, et al. Cloning and characterization of human estrogen receptor beta isoforms. Biochem Biophys Res Commun 1998; 247: 75-8. (Pubitemid 28412528)
26. Jassam N, Bell SM, Speirs V, et al. Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging. Oncol Rep 2005; 14: 17-21.
27. Arai T, Esaki Y, Sawabe M, et al. Hypermethylation of the hMLH1 promoter with absent hMLH1 expression in medullary-type poorly differentiated colorectal adenocarcinoma in the elderly. Mod Pathol 2004; 17: 172-9. (Pubitemid 41656513)
28. Wong NA, Malcomson RD, Jodrell DI, et al. ERbeta isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates. J Pathol 2005; 207: 53-60. (Pubitemid 41200714)
29. Campbell PT, Cotterchio M, Dicks E, et al. Excess body weight and colorectal cancer risk in Canada: associations in subgroups of clinically defined familial risk of cancer. Cancer Epidemiol Biomarkers Prev 2007; 16: 1735-44. (Pubitemid 47450502)
30. Laake I, Thune I, Selmer R, et al. A prospective study of body mass index, weight change, and risk of cancer in the proximal and distal colon. Cancer Epidemiol Biomarkers Prev 2010; 19: 1511-22.
31. Lin J, Zhang SM, Cook NR, et al. Body mass index and risk of colorectal cancer in women (United States). Cancer Causes Control 2004; 15: 581-9. (Pubitemid 39070076)
32. Slattery ML, Ballard-Barbash R, Edwards S, et al. Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes Control 2003; 14: 75-84. (Pubitemid 36403272)
33. Reeves GK, Pirie K, Beral V, et al. Cancer incidence and mortality in relation to body mass index in the million women study: cohort study. Br Med J 2007; 335: 1134.
34. Terry PD, Miller AB, Rohan TE,. Obesity and colorectal cancer risk in women. Gut 2002; 51: 191-4. (Pubitemid 34791445)
35. Giovannucci E, Michaud D,. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 2007; 132: 2208-25. (Pubitemid 46693749)
36. Kuiper GG, Lemmen JG, Carlsson B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998; 139: 4252-63. (Pubitemid 28513713)
37. Zhu BT, Han GZ, Shim JY, et al. Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: insights into the structural determinants favoring a differential subtype binding. Endocrinology 2006; 147: 4132-50.